top of page

Prevention Product Preference Brief

New products, including long-acting formulations, will be critical to achieve HIV treatment and prevention targets and close gaps among populations with unmet need. In June 2022, at a community forum on CAB-LA access, CHAI facilitated an interactive exercise to engage participants with real-time decision-making on pipeline products, facilitate discussion around choice, and distill insights related to product development, counseling, and demand generation. This brief summarizes the findings of that activity.

Related Posts

See All


bottom of page